Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (2134)
  2. Journal Article (1757)
  3. Review (262)
  4. Editorial (133)
  5. Research Letter (85)
  6. Correspondence (45)
  7. Book Section (31)
  8. Guidelines (25)
  9. Miscellaneous (14)
  10. Conference Paper (8)
Groups
  1. Department of Medicine (4175)
  2. Weinberg Fellows (2758)
  3. Hematologic Malignancies, Division of (2493)
  4. Solid Tumor Oncology Division (2424)
  5. Center for Hematologic Malignancies (1945)
  6. GSK Faculty (1879)

More Groups

People
  1. Sergio Giralt (433)
  2. Michael Scordo (389)
  3. Gunjan Shah (348)
  4. Miguel-Angel Perales (338)
  5. Sean Devlin (289)
  6. Marcel Van Den Brink (263)

More People

Years
  1. 2025 (346)
  2. 2024 (636)
  3. 2023 (600)
  4. 2022 (628)
  5. 2021 (503)
  6. 2020 (496)

More Years

Publications
  1. Blood (713)
  2. Journal of Clinical Oncology (685)
  3. Annals of Oncology (133)
  4. Clinical Cancer Research (131)
  5. Cancer Research (126)
  6. Biology of Blood and Marrow Transplantation (124)

More Publications

Publishers
  1. American Society of Hematology (806)
  2. American Society of Clinical Oncology (774)
  3. Elsevier Inc. (544)
  4. Nature Publishing Group (358)
  5. American Association for Cancer Research (352)
  6. Oxford University Press (211)

More Publishers

Results (4494)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Generation and characterization of patient-derived preclinical models from tumor cells isolated from cerebrospinal fluid
    Meeting Abstract

    Offin, M.; Vojnic, M.; Liu, Z.; Lui, A.; Siau, E.; Gladstone, E.; Mattar, M.; Khodos, I.; Drilon, A.; Boire, A.; more...
    Neuro-Oncology Advances (2019)

    Fulltext@MSK | Save
  • A multi-center dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of fimepinostat (CUDC-907) in combination with venetoclax in patients with relapsed/refractory (R/R) lymphoma
    Meeting Abstract

    Younes, A.; Batlevi, C. L.; Cohen, J. B.; de Vos, S.; Landsburg, D. J.; Myint, Z. W.; Patel, K.; Phillips, T. J.; Smith, S. M.; Westin, J. R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Inotuzumab ozogamicin is an effective salvage therapy in relapsed/refractory B-cell acute lymphoblastic leukemia with high-risk molecular features, including TP53 loss
    Meeting Abstract

    Yang, X.; King, A. C.; Kabel, C. C.; Forlenza, C. J.; Park, J. H.; Geyer, M. B.
    Blood (2019)

    Fulltext@MSK | Save
  • Toxicities and outcomes of acalabrutinib-treated patients with chronic lymphocytic leukemia: A retrospective analysis of real world patients
    Meeting Abstract

    Yazdy, M. S.; Mato, A. R.; Roeker, L. E.; Jarral, U.; Ujjani, C. S.; Shadman, M.; Skarbnik, A.; Whitaker, K. J.; Deonarine, I.; Kabel, C. C.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Highly favorable outcomes with salvage radiation therapy followed by autologous transplant in relapsed and refractory DLBCL patients with minimal or no response to salvage chemotherapy
    Meeting Abstract

    Yang, J. C.; Chau, K.; Scordo, M.; Sauter, C. S.; Yahalom, J.
    Blood (2019)

    Fulltext@MSK | Save
  • Tolerability and efficacy of crenolanib and cytarabine/anthracycline chemotherapy in older patients (aged 61 to 75) with newly diagnosed FLT3-mutated acute myeloid leukemia (AML)
    Meeting Abstract

    Wang, E. S.; Griffiths, E. A.; Walter, R. B.; Tallman, M. S.; Goldberg, A. D.; Messahel, B.; Stone, R. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients
    Meeting Abstract

    Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R.
    Blood (2019)

    Fulltext@MSK | Save
  • Current selection patterns, toxicities and outcomes of pre-transplant salvage treatment regimens in patients with relapsed/refractory Hodgkin lymphoma: Results of a multicenter retrospective analysis
    Meeting Abstract

    Svoboda, J.; Ballard, H. J.; Bair, S. M.; Banerjee, R.; Andreadis, C.; Feldman, T. A.; McCarthy, E. L.; Khan, N.; Moskowitz, A. J.; Orellana-Noia, V. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Financial incentives to increase stool collection rates for microbiome studies in adult bone marrow transplant patients
    Meeting Abstract

    Thompson, J. C.; Ren, Y.; Romero, K. M.; Lew, M. V.; Bush, A. T.; Messina, J. A.; Jung, S. H.; Miller, J. M.; Zenko, Z.; Jenq, R. R.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Annotation of somatic genomic variants in hematologic diseases using OncoKB, a precision oncology knowledgebase
    Meeting Abstract

    Suehnholz, S. P.; Kundra, R.; Roshal, M.; Xiao, W.; Petrova-Drus, K.; Yabe, M.; Ho, C.; Zhang, H.; Knorr, D.; Miles, L. A.; more...
    Blood (2019)

    Fulltext@MSK | Save